CXCL8 and triple-A syndrome: We show differences in the responsiveness of primary aortic cells to IL-8 and to serum from patients with AAA, and the modulatory effects over cell responses by the IL-8 receptor antagonist Lad, in the optics of viable therapeutic approaches against aortic damage.